Post Offer Free
Foshan Jiazhinuo Biotechnology Co.,Ltd
Foshan Jiazhinuo Biotechnology Co.,Ltd

China Entecavir 142217-69-4 Treat Hepatitis Pharma Raw Material manufacturer

4th

Gold Index: 91165

You are here: home  > Pharmaceuticals  > Entecavir 142217-69-4 Treat Hepatitis Pharma Raw Material

Entecavir 142217-69-4 Treat Hepatitis Pharma Raw Material 

Price: 1.0 USD 
Payment Terms: T/T,WU,Money Gram;Bitcoin 
Place of Origin: Guangdong, China (Mainland) 
inquire skype
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Means of Transport: Ocean,Land,Air
Packing: 25kg/Drum
Production Capacity: 1000kg/month
Delivery Date: 4days

Molecular Formula : C12H15N5O3
Molecular Weight : 277.28
Appearance:white powder
Assay: more than 99.5%
Single impurity: NMT0.1%

Entecavir Profile


Synonyms:2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one

CAS:142217-69-4

Molecular Formula : C12H15N5O3

Molecular Weight : 277.28

Appearance:white powder

Assay: more than 99.5%

Single impurity: NMT0.1%

Total impurity: NMT0.3%

Application: Anti Virus B Hepatic Disease

Packaging: 50-100g//aluminum foil bag

Storage: room temperature, keep in dry cool place

Product Tags: aluminum foil bag


Entecavir Description


Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. Entecavir is a nucleoside analog (more specifically, a guanosineanalogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process.


The drug's manufacturer claims that entecavir is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It also helps prevent the hepatitis B virus from multiplying and infecting new liver cells. Entecavir is also indicated for the treatment of chronic hepatitis B in adults with HIV/AIDS infection.



Usage and dosage


Patients should be under the guidance of an experienced doctor taking this product.


Recommended dose: adults and adults over the age of 16 oral, once a day, each 0.5mg. Lamivudine treatment occurred viremia or emergence of lamivudine-resistant mutations in patients once a day, each 1.0mg (0.5mg two).


This product should be taken on an empty stomach (at least 2 hours before or after a meal).


Ms. Karry
skype Ms. Karry
Sales Manager
Tel: 86-0757-82035343
Mobile: 86- 188 2631 2629
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on Hisupplier.com

Other products from this supplier

Company Info

Foshan Jiazhinuo Biotechnology Co.,Ltd [China (Mainland)]


Business Type:Manufacturer, Trading Company
City: Foshan
Province/State: Guangdong
Country/Region: China (Mainland)

Karry:   skype
Karry:   qq

You May Like: